Cell Biology and Toxicology

, Volume 26, Issue 1, pp 69–81

Multifunctional nanocomplexes for gene transfer and gene therapy

Article

DOI: 10.1007/s10565-009-9141-y

Cite this article as:
Hart, S.L. Cell Biol Toxicol (2010) 26: 69. doi:10.1007/s10565-009-9141-y

Abstract

DNA formulated into aggregates with polycationic reagents are referred to by a variety of terms including non-viral vectors, synthetic vectors, lipoplexes, polyplexes and more recently nanoparticles. The capacity for delivery of multiple genes, genomic-sized constructs and siRNA delivery, with a diversity of possible formulations, as well as the possibilities of improved efficiency of in vivo gene deliveries, means that nanoparticles, or nanocomplexes to reflect self-assembling systems, will be investigated with increasing vigour in the coming years. This review briefly outlines the applications and challenges for nanoparticle technologies in the field of gene therapy then focuses on the development of a specific kind of formulation, receptor-targeted nanocomplex (RTN), that we have found to be particularly useful in our gene therapy research. An overriding guiding concept that has emerged in the development of synthetic nanodelivery systems is the idea to develop formulations and structures that mimic viruses, whilst retaining the safety elements of synthetic, non-viral systems. RTNs have been optimised and developed for airway epithelial transfection, leading towards gene therapy for cystic fibrosis and for vascular transfection in vein grafts used in bypass surgery. The modular design of the RTN platform further allows for the testing of specific hypotheses relating to the structure and functional role of components in the formation of stable particles and in the transfection pathway, leading to their ultimate disassembly in the nucleus.

Keywords

TransfectionGene therapyNanoparticleNon-viralReceptor-mediatedTargeted

Abbreviations

RTN

Receptor-targeted nanocomplex

siRNA

Short interfering RNA

RNAi

RNA interference

SCID X1

Severe combined immunodeficiency disease type X1

bp

Base pairs

kb

Kilobase pairs

nt

Nucleotides

DOTMA

1,2-Di-((Z)-octadec-9-enyloxy)-N,N,N-trimethylammonium propane chloride

DOPE

Dioleoyl phosphatidylethanolamine

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Wolfson Centre for Gene Therapy of Childhood DiseaseUCL Institute of Child HealthLondonUK
  2. 2.Genex Biosystems Ltd.LondonUK
  3. 3.Molecular Immunology UnitUCL Institute of Child HealthLondonUK